Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Monday, April 14, 2025, on account of Dr. B. R. Ambedkar Jayanti.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Thacker & Co.ltd. Share Price

₹ 1290 0.00 (0.00%)

Apr 15 2025 12:00 AM Diversified NSE: THACKER

Thacker & Co.ltd. Share Price Update

As of the latest trading session, Thacker & Co.ltd. share price is currently at 1290, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 1210.00 and 1340.00. Over the past year, Thacker & Co.ltd. has achieved a return of 98.39 %. In the last month alone, the return has been -9.61 %. Read More...

Thacker & Co.ltd. Performance

Day Range

Low1210.00 High1340.00

1290.00

52 Week Range

Low 635.55 High 2282.85

1290.00

Thacker & Co.ltd. Share Price

509945

THACKER

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

1210.00

Prev. Close

1290.00

Volume (Shares)

58.00 Total traded value

.75

Upper Circuit

1548.00

Lower Circuit

1032.00

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Thacker & Co.ltd. Fundamentals

(Standalone)

Market Cap (Cr)	140.31
PE Ratio (TTM)	72.00
Book Value / Share	253.20
Beta	0.14

ROE	8.08%
EPS (TTM)	17.91
Dividend Yield	0.00%
Net Profit Qtr (Cr)	0.53

Thacker & Co.ltd. Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	0.72
Operating Expense	0.55
Net Profit	0.53
Net Profit Margin (%)	73.61
Earnings Per Share (EPS)	4.86
EBITDA	1.01
Effective Tax Rate (%)	23.18

Particulars	SEP 2024 (Values in Cr)
Revenue	0.52
Operating Expense	0.43
Net Profit	1.17
Net Profit Margin (%)	225.00
Earnings Per Share (EPS)	10.71
EBITDA	1.83
Effective Tax Rate (%)	22.51

Particulars	JUN 2024 (Values in Cr)
Revenue	0.52
Operating Expense	0.44
Net Profit	0.46
Net Profit Margin (%)	88.46
Earnings Per Share (EPS)	4.23
EBITDA	0.88
Effective Tax Rate (%)	19.29

Particulars	MAR 2024 (Values in Cr)
Revenue	0.51
Operating Expense	0.46
Net Profit	-0.21
Net Profit Margin (%)	-41.17
Earnings Per Share (EPS)	-1.89
EBITDA	0.90
Effective Tax Rate (%)	138.18

Particulars	DEC 2023 (Values in Cr)
Revenue	0.51
Operating Expense	0.48
Net Profit	0.34
Net Profit Margin (%)	66.66
Earnings Per Share (EPS)	3.10
EBITDA	0.88
Effective Tax Rate (%)	35.84

Particulars	MAR 2024 (Values in Cr)
Revenue	2.23
Operating Expense	1.88
Net Profit	1.79
Net Profit Margin (%)	80.26
Earnings Per Share (EPS)	16.42
EBITDA	4.48
Effective Tax Rate (%)	41.88

Particulars	MAR 2023 (Values in Cr)
Revenue	2.11
Operating Expense	1.99
Net Profit	2.25
Net Profit Margin (%)	106.63
Earnings Per Share (EPS)	20.70
EBITDA	4.37
Effective Tax Rate (%)	20.21

Particulars	MAR 2022 (Values in Cr)
Revenue	2.05
Operating Expense	2.14
Net Profit	2.45
Net Profit Margin (%)	119.51
Earnings Per Share (EPS)	22.54
EBITDA	4.64
Effective Tax Rate (%)	16.09

Particulars	MAR 2021 (Values in Cr)
Revenue	2.15
Operating Expense	2.67
Net Profit	1.18
Net Profit Margin (%)	54.88
Earnings Per Share (EPS)	10.85
EBITDA	3.49
Effective Tax Rate (%)	22.36

Particulars	MAR 2020 (Values in Cr)
Revenue	1.65
Operating Expense	3.08
Net Profit	1.37
Net Profit Margin (%)	83.03
Earnings Per Share (EPS)	12.60
EBITDA	3.78
Effective Tax Rate (%)	10.45

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	1137.77
ROE %	1.70
ROCE %	2.90
Total Debt to Total Equity	0.00
EBITDA Margin	208.93

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	912.83
ROE %	3.06
ROCE %	3.89
Total Debt to Total Equity	0.00
EBITDA Margin	178.08

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	781.37
ROE %	3.01
ROCE %	3.66
Total Debt to Total Equity	0.00
EBITDA Margin	85.39

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	654.57
ROE %	2.56
ROCE %	3.37
Total Debt to Total Equity	0.01
EBITDA Margin	78.44

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	558.97
ROE %	3.19
ROCE %	3.93
Total Debt to Total Equity	0.03
EBITDA Margin	93.74

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	219.97
ROE %	8.08
ROCE %	13.82
Total Debt to Total Equity	0.01
EBITDA Margin	200.90

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	187.20
ROE %	12.17
ROCE %	15.22
Total Debt to Total Equity	0.00
EBITDA Margin	207.58

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	152.79
ROE %	12.70
ROCE %	15.12
Total Debt to Total Equity	0.00
EBITDA Margin	192.20

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	116.38
ROE %	10.37
ROCE %	13.08
Total Debt to Total Equity	0.03
EBITDA Margin	162.33

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	92.79
ROE %	13.28
ROCE %	14.21
Total Debt to Total Equity	0.15
EBITDA Margin	229.09

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	0.81
Total Assets	138.90
Total Liabilities	138.90
Total Equity	136.78
Share Outstanding	1087719
Price to Book Ratio	3.18
Return on Assets (%)	13.01
Return on Capital (%)	13.19

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	1.24
Total Assets	114.85
Total Liabilities	114.85
Total Equity	113.67
Share Outstanding	1087719
Price to Book Ratio	1.74
Return on Assets (%)	10.89
Return on Capital (%)	11

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	2.85
Total Assets	102.62
Total Liabilities	102.62
Total Equity	100.87
Share Outstanding	1087719
Price to Book Ratio	2.09
Return on Assets (%)	9.12
Return on Capital (%)	9.28

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	2.55
Total Assets	90.85
Total Liabilities	90.85
Total Equity	88.74
Share Outstanding	1087719
Price to Book Ratio	1.81
Return on Assets (%)	7.43
Return on Capital (%)	7.62

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	2.05
Total Assets	83.01
Total Liabilities	83.01
Total Equity	80.18
Share Outstanding	1087719
Price to Book Ratio	0.97
Return on Assets (%)	8.84
Return on Capital (%)	9.16

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	0.56
Total Assets	38.90
Total Liabilities	38.90
Total Equity	36.92
Share Outstanding	1087944
Price to Book Ratio	3.18
Return on Assets (%)	4.59
Return on Capital (%)	4.81

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	0.56
Total Assets	35.78
Total Liabilities	35.78
Total Equity	34.72
Share Outstanding	1087944
Price to Book Ratio	1.74
Return on Assets (%)	6.29
Return on Capital (%)	6.48

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	1.12
Total Assets	33.58
Total Liabilities	33.58
Total Equity	32.48
Share Outstanding	1087944
Price to Book Ratio	2.09
Return on Assets (%)	7.30
Return on Capital (%)	7.55

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	1.25
Total Assets	31.35
Total Liabilities	31.35
Total Equity	30.19
Share Outstanding	1087944
Price to Book Ratio	1.81
Return on Assets (%)	3.76
Return on Capital (%)	3.91

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	0.61
Total Assets	31.41
Total Liabilities	31.41
Total Equity	29.46
Share Outstanding	1087944
Price to Book Ratio	0.97
Return on Assets (%)	4.36
Return on Capital (%)	4.65

Particulars	MAR 2024 (Values in Cr)
Net Income	3.22
Cash from Operations	-2.74
Cash from Investing	2.72
Cash from Financing	0.26
Net change in Cash	-0.43
Free Cash Flow	-2.74

Particulars	MAR 2023 (Values in Cr)
Net Income	3.58
Cash from Operations	-3.65
Cash from Investing	2.68
Cash from Financing	0.03
Net change in Cash	-1.69
Free Cash Flow	-3.65

Particulars	MAR 2022 (Values in Cr)
Net Income	3.54
Cash from Operations	-0.91
Cash from Investing	1.27
Cash from Financing	0.00
Net change in Cash	-0.26
Free Cash Flow	-0.91

Particulars	MAR 2021 (Values in Cr)
Net Income	2.21
Cash from Operations	-0.19
Cash from Investing	1.07
Cash from Financing	-0.58
Net change in Cash	0.50
Free Cash Flow	-0.19

Particulars	MAR 2020 (Values in Cr)
Net Income	2.19
Cash from Operations	0.45
Cash from Investing	1.38
Cash from Financing	-2.00
Net change in Cash	-0.27
Free Cash Flow	0.54

Particulars	MAR 2024 (Values in Cr)
Net Income	3.07
Cash from Operations	-2.21
Cash from Investing	2.67
Cash from Financing	0.16
Net change in Cash	0.00
Free Cash Flow	-2.21

Particulars	MAR 2023 (Values in Cr)
Net Income	2.82
Cash from Operations	-2.84
Cash from Investing	2.80
Cash from Financing	0.04
Net change in Cash	-0.56
Free Cash Flow	-2.84

Particulars	MAR 2022 (Values in Cr)
Net Income	2.91
Cash from Operations	-1.46
Cash from Investing	1.81
Cash from Financing	0.00
Net change in Cash	-0.12
Free Cash Flow	-1.46

Particulars	MAR 2021 (Values in Cr)
Net Income	1.52
Cash from Operations	-0.34
Cash from Investing	1.17
Cash from Financing	-0.58
Net change in Cash	0.64
Free Cash Flow	-0.34

Particulars	MAR 2020 (Values in Cr)
Net Income	1.52
Cash from Operations	-0.55
Cash from Investing	2.24
Cash from Financing	-1.68
Net change in Cash	-0.02
Free Cash Flow	-0.55

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
MAFATLAL INDUSTRIES LTD.	131.75	8.31	0.99	947.42	111.50 / 220.95
ANDREW YULE & COMPANY LTD.	25.48	0.00	3.46	1245.85	22.65 / 65.65
BALMER LAWRIE & CO LTD	187.35	12.11	1.79	3203.76	146.70 / 320.25
BOMBAY CYCLE & MOTOR AGENCY LT	1747.90	24.27	2.38	69.92	1392.10 / 2593.95

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
MAFATLAL INDUSTRIES LTD.	131.75	8.29	0.99	947.42	111.50 / 220.95
EMPIRE INDUSTRIES LTD.	1048.85	14.77	2.05	629.31	823.70 / 1599.00
ANDREW YULE & COMPANY LTD.	25.48	0.00	9.38	1245.85	22.65 / 65.65
BALMER LAWRIE & CO LTD	187.35	15.81	2.32	3203.76	146.70 / 320.25

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 1252.10
26 Days 1317.40
10 Days 1262.30
50 Days 1406.60
12 Days 1267.80
100 Days 1466.90
20 Days 1294.20
200 Days 1362.60

1280.23
PIVOT

First Resistance	1359.27
Second Resistance	1429.03
Third Resistance	1508.07

First Support	1210.47
Second Support	1131.43
Third Support	1061.67

RSI	47.59
MACD	-49.62
Commodity Channel Index (CCI)	-28.67

ADX	10.06
Williams % R	-57.54

Thacker & Co.ltd. Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

28.07 Promoter Holdings

64.27 FII

0.0 DII

7.64 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
Suma Commercial Private Limited	Shareholding of Promoter and Promoter Group	342690.0	31.51
Arunkumar Mahabirprasad Jatia	Shareholding of Promoter and Promoter Group	146962.0	13.51
Yashvardhan Jatia Trust (arun Kumar Mahabir Prasad Jatia, Gautam N Jajodia, Trustees Of The Trust)	Shareholding of Promoter and Promoter Group	118410.0	10.89
Bank Of India	Public Shareholding	83159.0	7.65
Chem Mach Private Limited	Shareholding of Promoter and Promoter Group	65000.0	5.98
Stone Masters India Private Limited	Public Shareholding	61274.0	5.63
Asi Industries Limited	Public Shareholding	58460.0	5.37
Thacker And Company Limited Unclaimed Sh	Public Shareholding	48972.0	4.5
Kishor Uttam Naik	Public Shareholding	15178.0	1.4
Vrinda Jatia Trust (arun Kumar Mahabir Prasad Jatia, Gautam N Jajodia, Trustees Of The Trust)	Shareholding of Promoter and Promoter Group	15000.0	1.38
Manju Gaggar	Public Shareholding	11171.0	1.03
Vasudha Jatia Trust (arun Kumar Mahabir Prasad Jatia, Gautam N Jajodia, Trustees Of The Trust)	Shareholding of Promoter and Promoter Group	11000.0	1.01
Yashvardhan Jatia	Shareholding of Promoter and Promoter Group	100.0	0.01
Vasudha Jatia	Shareholding of Promoter and Promoter Group	0.0	0.0
Vrinda Jatia	Shareholding of Promoter and Promoter Group	0.0	0.0
Arun Jatia Huf	Shareholding of Promoter and Promoter Group	0.0	0.0
Mahabir Prasad Jatia Family Trust	Shareholding of Promoter and Promoter Group	0.0	0.0
Biodegradable Products India Limited	Shareholding of Promoter and Promoter Group	0.0	0.0
3p Land Holdings Limited	Shareholding of Promoter and Promoter Group	0.0	0.0
Amj Land Holdings Limited	Shareholding of Promoter and Promoter Group	0.0	0.0
Pudumjee Paper Products Limited	Shareholding of Promoter and Promoter Group	0.0	0.0
Fujisan Technologies Limited	Shareholding of Promoter and Promoter Group	0.0	0.0

Thacker & Co.ltd.

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type

Learn More About Stocks

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

HAL Denies Selecting PwC for R&D Benchmarking Amid Ongoing Bids

HAL clarifies no consultancy firm has been finalised for R&D benchmarking amid social media buzz about PwC. Selection process still ongoing via GeM portal.

15 Apr, 2025 | 3 Min. read

Aurobindo Pharma Gets USFDA Nod for Generic Xarelto 2.5mg Tablets

Aurobindo Pharma receives USFDA approval to launch generic Xarelto 2.5mg in Q1 FY26, targeting $447 million US market; higher strengths also gain tentative nod.

15 Apr, 2025 | 3 Min. read

IndiGo Becomes World’s Most Valuable Airline With $23.4 Billion Market Cap

IndiGo surpasses global peers to become the most valuable airline by market cap at $23.4 billion, pushing InterGlobe Aviation share price to record highs in 2025.

11 Apr, 2025 | 3 Min. read

SRF Ltd. Commissions New Agrochemical Unit in Dahej Worth Rs.239 Crore

SRF Ltd. starts new agrochemical facility in Dahej, Gujarat with Rs.239 crore investment. Phase 1 operational, full commissioning set for April 2025.

11 Apr, 2025 | 3 Min. read

Tata Motors’ JLR India Achieves Record Sales in FY25 at 6,183 Units

JLR India posts record-breaking FY25 retail sales of 6,183 units, up 40%. Defender leads growth, boosting Tata Motors share price sentiment.

11 Apr, 2025 | 4 Min. read

Biocon Gets USFDA Approval for Jobevne, Expands Oncology Portfolio

Biocon Biologics receives USFDA nod for cancer drug Jobevne, a bevacizumab biosimilar. Oncology portfolio in US grows, boosting Biocon Ltd. share price outlook.

11 Apr, 2025 | 3 Min. read